Andreas Agathangelidis is an Assistant Professor of Genetics-Molecular Genetics of Eukaryotic Organisms in the Department of Biology of the National and Kapodistrian University of Athens and his research focuses on the field of Cancer Genetics. His work aims to improve the understanding of biology and the therapeutic targeting of cancer.
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults. Although in many patients the disease progresses slowly and remains stable for many years, in others it exhibits aggressive behavior and limited response to treatment. This great heterogeneity makes it difficult to accurately predict the disease and choose the most appropriate therapeutic strategy.
Recent studies have shown that CLL cancer cells carry on their surface a unique “molecular receptor”, the B-cell receptor, which plays a crucial role in the development and progression of the disease. Groups of patients with particularly similar receptors form the so-called stereotyped subsets, which are associated with specific biological characteristics and clinical course of the disease. Some of these subsets are already associated with an unfavorable prognosis and an increased risk of clinical complications.
The stereoCLLassifier research project, which will be the product of collaboration between the Department of Biology of the National and Kapodistrian University of Athens and the Institute of Applied Biosciences of the National Centre for Research and Technology Hellas, will exploit this knowledge and focus not only on the main, well-studied high-risk stereotyped subsets, but also on smaller, less well-known “satellite” subsets that appear to be closely associated with them. Although satellite subsets affect a significant number of patients, their role in the biology and clinical behavior of the disease remains largely unexplored.
Using modern and integrated methods that combine genetic, molecular and functional analyses, the project aims to uncover the mechanisms that lead to aggressive forms of CLL. The long-term goal is to improve the molecular classification of the disease and support more accurate prognosis and personalized treatments.
This project is supported by the Hellenic Foundation for Research and Innovation (https://www.elidek.gr/en/) within the framework of the “3rd Announcement and Guide for the Management and Implementation of Research Projects for the Support of Faculty Members and Researchers” in the Scientific Area “Life Sciences”.